MEMary E. BrunkowNov 10, 2024New paperautoPaperMulti-Omic characterization of the effects of Ocrelizumab in patients with relapsing-remitting multiple sclerosisJournal of the Neurological Sciences · 2024 · Sergey A Kornilov, Nathan D Price, Richard Gelinas et al.